Elisha Y. Goldberg
Plus aucun poste en cours
75 ans
Health Technology
Historique de carrière de Elisha Y. Goldberg
Anciens postes connus de Elisha Y. Goldberg
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ANGN BIOM | Corporate Officer/Principal | - | 31/01/2022 |
Statistiques
Internationale
| Etats-Unis | 2 |
Opérationnelle
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Angion Biomedica Corp.
 Angion Biomedica Corp. Pharmaceuticals: MajorHealth Technology Angion Biomedica Corp. operates as a biopharmaceutical company. The firm focuses on the discovery and development of novel therapeutic agents to address acute organ injuries and fibrotic diseases. Its product pipeline includes ANG-3777, ANG-3070, ROCK2 Inhibitor and CYP11B2 Inhibitors. The company was founded by Itzhak D. Goldberg on April 6, 1998 and is headquartered in Newton, MA. | Health Technology |
- Bourse
- Insiders
- Elisha Y. Goldberg
- Expérience